Risk Of Developing Liver Cancer After HCV Treatment

Sunday, May 29, 2011

Video/Vertex Incivek Patient Steve Goodwin On Telaprevir


At SFGate is a video interview with Steve Goodwin a patient who underwent HCV therapy with Incivek, better known as telaprevir. Steve is a genotype 1 null responder, see his video below.
You can read Mr. Goodwins paper on Incivek here.
   
 

Package Inserts for Peginterferon alfa and Ribavirin

Patient Assistance Program
INCIVEK/Telaprevir and VICTRELIS (Boceprevir) Patient Assistance Programs

FDA May 23, 2011 Teleconference Briefing on Direct Acting Antivirals, Victrelis (boceprevir) and Incivek (telaprevir) transcript
..
New two part video from Melissa Palmer, M.D. on Telaprevir (Vertex Pharmaceuticals) & Boceprevir (Merck), the new protease inhibitor treatments for hepatitis C (HCV).
.
From The AIDS Beacon
This article is first in a two-part series that will discuss the benefits and drawbacks of two drugs, boceprevir and telaprevir, which are being developed for hepatitis C. Part 1 discusses the efficacy of the two drugs in clinical trials. Part 2 discusses the complications and side effects for each drug


No comments:

Post a Comment